1.Dialyzer Thrombogenicity and Heparinized.
Korean Journal of Nephrology 2003;22(4):337-339
No abstract available.
Heparin*
2.A new mixture ratio of heparin for the cell salvage device.
Korean Journal of Anesthesiology 2011;60(3):226-226
No abstract available.
Heparin
3.Interaction of Heparin with protein
Journal of Medical Research 2000;11(1):69-72
5.Priapism : Report of Two Cases.
Kyu Wook PARK ; Sang Tai HAH ; Jong Byung YOON
Korean Journal of Urology 1981;22(5):469-472
Priapism is a condition of prolonged erection, unassociated with sexual stimulation, which is usually painful We experienced two cases of idiopathic priapism, the one was cured by the corporal irrigation with normal saline containing heparin through the glans tip and the other by the corpora cavernosa-saphenous vein shunt. Postoperatively potency in these two cases was obtained.
Heparin
;
Priapism*
;
Veins
6.Acute Stent Thrombosis and Heparin Induced Thrombocytopenia: Another Manifestation of Kounis Syndrome?.
Nicholas G KOUNIS ; George D SOUFRAS ; George ALMPANIS ; Grigorios TSIGKAS ; Andreas MAZARAKIS
Korean Circulation Journal 2013;43(4):221-222
No abstract available.
Heparin
;
Stents
;
Thrombosis
7.Heparin Therapy for Disseminated Intravascular Coagulation in Childhood.
Byung Ryul CHOI ; Yong Hoon PARK ; Jeong Ok HAH
Journal of the Korean Pediatric Society 1987;30(6):658-663
No abstract available.
Disseminated Intravascular Coagulation*
;
Heparin*
8.Thrombocytopenia caused by low-dose heparin supplementation of parenteral nutrition solution.
Eunyoung LEE ; Jeong Ok LEE ; Yoojoo LIM ; Ji Yeon KIM ; Hyun Kyung KIM ; Soo Mee BANG
Blood Research 2013;48(2):160-163
No abstract available.
Heparin
;
Parenteral Nutrition
;
Thrombocytopenia
9.Immune complex-induced increases in collagen production by cultured mesangial cells modulated by dexamthasone and heparin.
Chun Gyoo IHM ; Jae Kyung PARK ; Jae Hyung AHN ; Tae Won LEE ; Myung Jae KIM
Korean Journal of Nephrology 1992;11(3):207-213
No abstract available.
Collagen*
;
Heparin*
;
Mesangial Cells*
10.Research progress of heparinase in the field of medicine.
Wenli LIU ; Yingzi JIANG ; Liqing ZHAO ; Peixin ZHANG ; Shulan WANG
Chinese Journal of Biotechnology 2018;34(12):1953-1962
Heparinases can produce biologically active oligosaccharides by specifically cleaving the α-(1,4) glycosidic linkages of heparin and heparan sulphate. Heparinases are divided into heparinase and heparanase. Because heparinase is an effective biocatalyst, more and more researchers pay attention to the application of heparinase in medical field in the recent years. Combined with the related research work in our group, the application value of heparinase in the medical field was summarized, such as the determination of the structure of heparin, the preparation of low-molecular-weight heparin and ultra-low-molecular-weight heparin, tumor therapy and as a heparin antagonist. In addition, we summarized the definition, source of heparinase and its application in the medicine field. Heparinases have a great application prospect in the field of medicine.
Heparin
;
Heparin Lyase
;
metabolism
;
Heparitin Sulfate
;
Oligosaccharides
;
Polysaccharide-Lyases